Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01529437 · ClinicalTrials.gov registry record · Phase 1
Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
NCT01529437: Completed Phase 1 study, sponsored by Stanford University.
NCT01529437 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01529437, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a study for children and adults who are interested in a new therapy for their allergies to dust mite and timothy grass. The new therapy is called sublingual immunotherapy and the investigators are testing if it is safe and well tolerated.
Interventions
- DRUG sublingual immunotherapy
- DRUG placebo sublingual immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2005-01 |
| Est. Completion | 2014-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01529437
The ClinicalTrials.gov registry entry for NCT01529437 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sublingual immunotherapy is the first listed.
NCT01529437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01529437 about?
NCT01529437 is a clinical study titled "Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies". This is a study for children and adults who are interested in a new therapy for their allergies to dust mite and timothy grass. The new therapy is called sublingual immunotherapy and the investigators are testing if it is safe and well tolerated.
What is the current status of trial NCT01529437?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2005-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01529437?
The interventions under investigation include: sublingual immunotherapy (DRUG), placebo sublingual immunotherapy (DRUG).
Who is sponsoring clinical trial NCT01529437?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.